aer002
-
Trial Report SARS-CoV-2-specific monoclonal antibody AER002 in Long COVID: an exploratory randomized phase 2a mechanistic trial, 2026, Peluso et al
Now published, see post #13. Preprint: A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002 in people with Long COVID Long COVID is a disabling chronic illness with no proven treatments. Persistence of SARS-CoV-2 has been...- SNT Gatchaman
- Thread
- aer002 monoclonal antibody null result peluso psychologisation
- Replies: 12
- Forum: Long Covid research
-
J
No “easy home runs”: Early Long COVID trials of Paxlovid and monoclonal antibodies failed, but the treatments still have potential Sick Times (AER002)
https://thesicktimes.org/2025/08/12/no-easy-home-runs-early-long-covid-trials-of-paxlovid-and-monoclonal-antibodies-failed-but-the-treatments-still-have-potential/- Jaybee00
- Thread
- aer002 peluso
- Replies: 10
- Forum: Long Covid news